Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 24 biotech companies ranked by cash on hand, at CHF 7.7B, ahead of BioNTech (CHF 7.2B) and Gilead Sciences (CHF 6.4B). Figures as of 18 Nov 2026, 20:14 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenCHF 7.7B
Median
CHF 365.5M
Combined market value
CHF 706.5B
Countries
5

Market values as of .

All countries
All sectors
Biotech
CHF
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareCHF 7.7BCHF 202.5BCHF 374.35 3.12% down 34% up United States
2BioNTechBNTX · Health CareCHF 7.2BCHF 17.5BCHF 70.56 1.47% down 16% down Germany
3Gilead SciencesGILD · Health CareCHF 6.4BCHF 176.9BCHF 142.62 0.74% down 33% up United States
4argenxARGX · Health CareCHF 2.9BCHF 50.1BCHF 796.99 0.32% down 4% up Belgium
5BiogenBIIB · Health CareCHF 2.5BCHF 31.2BCHF 210.91 0.34% down 49% up United States
6ModernaMRNA · Health CareCHF 2.2BCHF 67.7BCHF 167.37 4.09% down 755% up United States
7ImmunovantIMVT · Health CareCHF 761.3MCHF 5.8BCHF 28.15 0.45% up 43% up United States
8QiagenQGEN · Health CareCHF 708MCHF 8.6BCHF 41.86 0.29% down 12% up Netherlands
9Neurocrine BiosciencesNBIX · Health CareCHF 601.7MCHF 13.9BCHF 137.51 1.79% down 20% up United States
10RepligenRGEN · Health CareCHF 477.6MCHF 9.3BCHF 145.76 6.51% up 5% up United States
11Krystal BiotechKRYS · Health CareCHF 418.8MCHF 7.9BCHF 264.96 5.17% up 46% up United States
12ExelixisEXEL · Health CareCHF 407.2MCHF 14.1BCHF 57.83 0.04% up 63% up United States
13Revolution MedicinesRVMD · Health CareCHF 323.8MCHF 29.2BCHF 134.84 1.79% down 131% up United States
14Kymera TherapeuticsKYMR · Health CareCHF 301.3MCHF 8.7BCHF 102.33 0.21% down 87% up United States
15CRISPR TherapeuticsCRSP · Health CareCHF 293.3MCHF 3.3BCHF 34.22 1.00% up 21% down Switzerland
16Scholar Rock HoldingSRRK · Health CareCHF 273MCHF 4.9BCHF 40.53 6.54% up 14% up United States
17Bio-TechneTECH · Health CareCHF 223.4MCHF 9.6BCHF 61.42 0.21% up 26% up United States
18Kodiak SciencesKOD · Health CareCHF 177.1MCHF 5.4BCHF 82.19 0.61% up 396% up United States
19Twist BioscienceTWST · Health CareCHF 154.5MCHF 6.7BCHF 98.39 4.11% up 340% up United States
20VaxcytePCVX · Health CareCHF 146.8MCHF 7.8BCHF 49.42 1.40% down 22% up United States
21Halozyme TherapeuticsHALO · Health CareCHF 112.9MCHF 9.2BCHF 81.13 0.18% up 37% up United States
22ImmunityBioIBRX · Health CareCHF 74.5MCHF 6BCHF 5.63 6.67% up 193% up United States
23Adaptive BiotechnologiesADPT · Health CareCHF 59.5MCHF 3.9BCHF 24.13 0.39% up 88% up United States
24CG OncologyCGON · Health CareCHF 27.4MCHF 6BCHF 67.59 1.47% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8439 CHF).

Questions and answers

Which biotech companies rank first by cash on hand?

Amgen (CHF 7.7B), BioNTech (CHF 7.2B) and Gilead Sciences (CHF 6.4B) are the top three of the 24 biotech companies ranked by cash on hand as of 18 Nov 2026, 20:14 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of CHF 706.5B as of 18 Nov 2026, 20:14 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.